These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 30542729)
21. Non-caspase-mediated apoptosis contributes to the potent cytotoxicity of the enediyne antibiotic lidamycin toward human tumor cells. Wang Z; He Q; Liang Y; Wang D; Li YY; Li D Biochem Pharmacol; 2003 Jun; 65(11):1767-75. PubMed ID: 12781328 [TBL] [Abstract][Full Text] [Related]
22. [The synergistic effect of lidamycin and rituximab on human B cell lymphoma]. Sun YR; Zhang SH; Shao RG; He HW Yao Xue Xue Bao; 2014 Feb; 49(2):198-203. PubMed ID: 24761609 [TBL] [Abstract][Full Text] [Related]
23. Lidamycin shows highly potent cytotoxic to myeloma cells and inhibits tumor growth in mice. Zhen YZ; Lin YJ; Li Y; Zhen YS Acta Pharmacol Sin; 2009 Jul; 30(7):1025-32. PubMed ID: 19575006 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571. Koyama N; Koschmieder S; Tyagi S; Portero-Robles I; Chromic J; Myloch S; Nürnberger H; Rossmanith T; Hofmann WK; Hoelzer D; Ottmann OG Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2025-31. PubMed ID: 16609011 [TBL] [Abstract][Full Text] [Related]
25. Enediyne lidamycin enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib, in epidermoid carcinoma A431 cells and lung carcinoma H460 cells. Liu H; Li L; Li XQ; Liu XJ; Zhen YS Anticancer Drugs; 2009 Jan; 20(1):41-9. PubMed ID: 19342999 [TBL] [Abstract][Full Text] [Related]
26. Induction of G2/M phase arrest and apoptosis by a novel enediyne derivative, THDA, in chronic myeloid leukemia (K562) cells. Wu ZZ; Chien CM; Yang SH; Lin YH; Hu XW; Lu YJ; Wu MJ; Lin SR Mol Cell Biochem; 2006 Nov; 292(1-2):99-105. PubMed ID: 16733797 [TBL] [Abstract][Full Text] [Related]
27. Saponins from Rubus parvifolius L. induce apoptosis in human chronic myeloid leukemia cells through AMPK activation and STAT3 inhibition. Ge YQ; Xu XF; Yang B; Chen Z; Cheng RB Asian Pac J Cancer Prev; 2014; 15(13):5455-61. PubMed ID: 25041018 [TBL] [Abstract][Full Text] [Related]
28. Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin. Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS Cancer Biol Ther; 2014 Apr; 15(4):398-408. PubMed ID: 24424202 [TBL] [Abstract][Full Text] [Related]
29. E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents. Stiewe T; Parssanedjad K; Esche H; Opalka B; Pützer BM Cancer Res; 2000 Jul; 60(14):3957-64. PubMed ID: 10919674 [TBL] [Abstract][Full Text] [Related]
30. Bortezomid enhances the efficacy of lidamycin against human multiple myeloma cells. Zhen YZ; Lin YJ; Liu XJ; Shang BY; Zhen YS Anticancer Drugs; 2013 Jul; 24(6):609-16. PubMed ID: 23698252 [TBL] [Abstract][Full Text] [Related]
31. Induction of human chronic myeloid leukemia K562 cell apoptosis by virosecurinine and its molecular mechanism. Zhang G; Li M; Han S; Chen D; Wang Y; Ye W; Ji Z Mol Med Rep; 2014 Nov; 10(5):2365-71. PubMed ID: 25189629 [TBL] [Abstract][Full Text] [Related]
32. Long Noncoding RNA (lncRNA) Small Nucleolar RNA Host Gene 5 (SNHG5) Regulates Proliferation, Differentiation, and Apoptosis of K562 Cells in Chronic Myeliod Leukemia. Gao B; Li S; Li G Med Sci Monit; 2019 Sep; 25():6812-6819. PubMed ID: 31506418 [TBL] [Abstract][Full Text] [Related]
33. Investigation of the Roles of Non-neuronal Acetylcholine in Chronic Myeloid Leukemic Cells and their Erythroid or Megakaryocytic Differentiated Lines. Aydın B; Cabadak H; Gören MZ Anticancer Agents Med Chem; 2018; 18(10):1440-1447. PubMed ID: 29623856 [TBL] [Abstract][Full Text] [Related]
34. Angelica sinensis polysaccharide induces erythroid differentiation of human chronic myelogenous leukemia k562 cells. Wang L; Jiang R; Song SD; Hua ZS; Wang JW; Wang YP Asian Pac J Cancer Prev; 2015; 16(9):3715-21. PubMed ID: 25987027 [TBL] [Abstract][Full Text] [Related]
35. Comparative study of DNA damage, cell cycle and apoptosis in human K562 and CCRF-CEM leukemia cells: role of BCR/ABL in therapeutic resistance. Pytel D; Wysocki T; Majsterek I Comp Biochem Physiol C Toxicol Pharmacol; 2006 Sep; 144(1):85-92. PubMed ID: 16904383 [TBL] [Abstract][Full Text] [Related]
36. Puerarin leads to K562 cell apoptosis of chronic myelogenous leukemia via induction of autophagy. Gao D; Xiao Z; Li HP J BUON; 2017; 22(6):1554-1562. PubMed ID: 29332352 [TBL] [Abstract][Full Text] [Related]
37. Quercetin Promotes Cell Cycle Arrest and Apoptosis and Attenuates the Proliferation of Human Chronic Myeloid Leukemia Cell Line-K562 Through Interaction with HSPs (70 and 90), MAT2A and FOXM1. Hassanzadeh A; Hosseinzadeh E; Rezapour S; Vahedi G; Haghnavaz N; Marofi F Anticancer Agents Med Chem; 2019; 19(12):1523-1534. PubMed ID: 31362681 [TBL] [Abstract][Full Text] [Related]
38. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway. Wei YL; Liang Y; Xu L; Zhao XY Anat Rec (Hoboken); 2009 Jul; 292(7):945-50. PubMed ID: 19548306 [TBL] [Abstract][Full Text] [Related]
39. Lidamycin induces neural differentiation of mouse embryonic carcinoma cells through down-regulation of transcription factor Oct4. Zhen HY; He QH; Li Y; Zhou J; Yao C; Liu YN; Ma LJ Biochem Biophys Res Commun; 2012 Apr; 421(1):44-50. PubMed ID: 22480685 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of mouse embryonic carcinoma cell growth by lidamycin through down-regulation of embryonic stem cell-like genes Oct4, Sox2 and Myc. Zhen HY; He QH; Zhen YZ; Wang SL; Liu YN; Wu WH; Zhang XY; Lu AL; Shen L Invest New Drugs; 2011 Dec; 29(6):1188-97. PubMed ID: 20596749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]